Quantoom Biosciences
- 0744.643.858
- BE0744643858
- rue de la Maitrise 11, 1400 Nivelles
- See the 3 companies at this address
- 2 March 2020
Profile
Official information from the CBE (FPS Economy).
Quantoom Biosciences is a Belgian company (Société anonyme) whose registered office is established at 1400 Nivelles. Its main activity falls under “Recherche-développement en biotechnologie” (NACE 72101).
- Legal form
- Société anonyme
- Legal situation
- Ouverture de faillite
- Date of incorporation
- 2 March 2020
- Main activity (NACE)
- 72101Recherche-développement en biotechnologie
An activity that is, on the face of it, not covered by anti-money-laundering law. Learn more
Secondary activities
3 additional NACE codes declared.
Your risk analysis on this company
AML Company ran Quantoom Biosciences through your due diligence questionnaire. Here are the first findings.
What is the geographic exposure of the client and of its transactions?
Belgium only· Registered office published in the register
What is the company's solvency and lifecycle status?
Declared bankrupt· Legal situation published in the register
Sanctions screening, politically exposed persons, ultimate beneficial owners, source of funds: AML Company runs them, documents them and keeps the proof in your file.
Run the full analysisThis preview is not a due diligence measure: it pre-qualifies questions from public data. Identifying the client and its ultimate beneficial owners requires documents collected and verified.
Establishments
3 active establishment units declared with the CBE.
3 establishments · 3 municipalities
Finances & financial health
Annual accounts filed with the Central Balance Sheet Office (CBSO, National Bank of Belgium) and an aggregate health score (Altman Z″ model, completed with qualitative factors).
Equity & result
| Financial year | Equity | Result | Turnover / gross margin | Headcount (FTE) |
|---|---|---|---|---|
| 2023 | -€1,176,622 | -€14,230,664 | €8,273,283turnover | 69,1 |
| 2022 | €9,694,354 | -€11,577,461 | - | 49,4 |
| 2021 | €8,571,441 | -€7,688,909 | - | 40,1 |
| 2020 | – | – | - | – |
Financial ratios
Solvency, liquidity and profitability, computed year by year from the filed annual accounts.
Equity / balance sheet total
Current assets / debts due within one year
Result for the year / turnover
Operating result / turnover
Debts due after one year / balance sheet total
The filed denominator is zero or negative: the ratio would carry no meaning.
Result for the year / equity
Balance sheet structure
| Ratio | 2023 | 2022 | 2021 | Trend |
|---|---|---|---|---|
| Solvency | -2,1% 30,4% | 28,4% 0,4% | 28% | |
| Liquidity | 3,26 x 0,78 | 2,49 x 0,27 | 2,76 x | |
| Net margin | -172% | - | - | - |
| Operating margin | -174,6% | - | - | - |
| Long-term debt | 0,1% 1,1% | 1,1% 1,8% | 2,9% | |
| Return on equity | - | -119,4% 29,7% | -89,7% |
Ratios computed by AML Company from the items filed in the balance sheet and the income statement. They are not filed figures as such: the underlying amounts appear in the key figures above.
Filing history (4)▾
Source: CBSO (NBB) filings, Belgian chart-of-accounts headings 9904 (result), 10/15 (equity), 9900 (gross margin), 9087 (workforce in FTE). Data available for filings from 2022 onwards.
The grade, the score out of 100, the Altman Z″ zone and the list of public alerts are for members only.
Notices in the Belgian Official Gazette
Official acts and notices: incorporation, changes to the articles, appointments, dissolutions.
- DEMISSIONS, NOMINATIONS20 September 2023
Source: Belgian Official Gazette (FPS Justice). The links open the official PDFs.
What the Quantoom Biosciences record does not say
Two readings of the register the raw data does not give: anti-money-laundering scope, and whether the filing deadline was met.
Is Quantoom Biosciences subject to anti-money-laundering obligations in Belgium?
Did Quantoom Biosciences file its annual accounts on time?
Company timeline
Every dated event in the company's life, from filed accounts to notices published in the Belgian Official Gazette, in a single thread.
10 AI-analysed dimensions are not shown.
- 2025
- 2024
- 4 July 2024Annual accounts filed·Financial year ended 31 December 2023 · Model m02-fFiled accounts2024-00237083
- 26 February 2024Articles of association · Capital · Shares · Appointments · ResignationsView the notice24366758
- 2023
- 12 July 2023Annual accounts filed·Financial year ended 31 December 2022 · Model m02-fFiled accounts2023-00228821
- 2022
- 22 July 2022Annual accounts filed·Financial year ended 31 December 2021 · Model m02-fFiled accounts2022-20219177
- 2021
- 18 June 2021Annual accounts filed·Financial year ended 31 December 2020 · Model m02-f-pFiled accounts2021-22900100
Registry record since 7 September 2026
The KBO publishes its changes as a monthly delta and never restates the past: our record starts on that date, not at the company's incorporation. No change recorded since that date. A missing row says nothing about the company, only about how far back our record goes.
AI extraction of strategic AML data
The official notices in the Belgian Official Gazette are analysed by our AI engine to extract automatically the information that matters for your due diligence and your AML duties.
- Legal life
- Restructuring
- Capital
- Legal form
- Incorporation
- Directors
- Beneficial owners
- Registered office
- Company name
- Notarial deeds
Similar companies
Same business sector and geographic area.
Phoenix Biosciences
UCB PHARMA
Laboratoires Sterop
Pfizer
-HEEL BELGIUM
Will - Pharma
ROCHE
BAXTER
Unda
Step it up
Full analysis unlocked.
Create an account to unlock the detailed analysis: health score, full history, alerts and PDF exports.